FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2986002359> ?p ?o ?g. }

• W2986002359 endingPage "849" @default.
• W2986002359 startingPage "840" @default.
• W2986002359 abstract "The thoracic radiotherapy (TRT) target volume for limited-stage small-cell lung cancer (SCLC) has been controversial for decades. In this report, the final results of a prospective randomized trial on the TRT target volume before and after induction chemotherapy are presented.After 2 cycles of etoposide and cisplatin, patients arm were randomized to receive TRT to the postchemotherapy or prechemotherapy tumor volume in a study arm and a control arm. Involved-field radiotherapy was received in both arms. TRT consisted of 1.5 grays (Gy) twice daily in 30 fractions to up to a total dose of 45 Gy. Lymph node regions were contoured, and intentional and incidental radiation doses were recorded.The study was halted early because of slow accrual. Between 2002 and 2017, 159 and 150 patients were randomized to the study arm or the control arm, respectively; and 21.4% and 19.1% of patients, respectively, were staged using positron emission tomography/computed tomography (P = .31). With a median follow-up of 54.1 months (range, 19.9-165.0 months) in survivors, the 3-year local/regional progression-free probability was 58.2% and 65.5% in the study and control arms, respectively (P = .44), and the absolute difference was -7.3% (95% CI, -18.2%, 3.7%). In the study and control arms, the median overall survival was 21.9 months and 26.6 months, respectively, and the 5-year overall survival rate was 22.8% and 28.1%, respectively (P = .26). Grade 3 esophagitis was observed in 5.9% of patients in the study arm versus 15.5% of those in the control arm (P = .01). The isolated out-of-field failure rate was 2.6% in the study arm versus 4.1% in the control arm (P = .46), and all such failures were located in the supraclavicular fossa or contralateral hilum. The regions 7, 3P, 4L, 6, 4R, 5, and 2L received incidental radiation doses >30 Gy.TRT could be limited to the postchemotherapy tumor volume, and involved-field radiotherapy could be routinely applied for limited-stage SCLC." @default.
• W2986002359 created "2019-11-22" @default.
• W2986002359 creator A5003967203 @default.
• W2986002359 creator A5004226726 @default.
• W2986002359 creator A5004613692 @default.
• W2986002359 creator A5006883181 @default.
• W2986002359 creator A5007444000 @default.
• W2986002359 creator A5009520487 @default.
• W2986002359 creator A5011303359 @default.
• W2986002359 creator A5015462888 @default.
• W2986002359 creator A5018964484 @default.
• W2986002359 creator A5019256105 @default.
• W2986002359 creator A5028187841 @default.
• W2986002359 creator A5028727210 @default.
• W2986002359 creator A5034807554 @default.
• W2986002359 creator A5041181413 @default.
• W2986002359 creator A5047460475 @default.
• W2986002359 creator A5048290265 @default.
• W2986002359 creator A5050593912 @default.
• W2986002359 creator A5052805520 @default.
• W2986002359 creator A5056742440 @default.
• W2986002359 creator A5060480519 @default.
• W2986002359 creator A5064792356 @default.
• W2986002359 creator A5066716873 @default.
• W2986002359 creator A5069216833 @default.
• W2986002359 creator A5069273530 @default.
• W2986002359 creator A5070184832 @default.
• W2986002359 creator A5070734136 @default.
• W2986002359 creator A5073022247 @default.
• W2986002359 creator A5073245531 @default.
• W2986002359 creator A5076858524 @default.
• W2986002359 creator A5085715767 @default.
• W2986002359 creator A5087390816 @default.
• W2986002359 creator A5088179029 @default.
• W2986002359 date "2019-11-12" @default.
• W2986002359 modified "2023-10-14" @default.
• W2986002359 title "Final report of a prospective randomized study on thoracic radiotherapy target volume for limited‐stage small cell lung cancer with radiation dosimetric analyses" @default.
• W2986002359 cites W1552379896 @default.
• W2986002359 cites W1905406155 @default.
• W2986002359 cites W1923792259 @default.
• W2986002359 cites W1973510243 @default.
• W2986002359 cites W1976228473 @default.
• W2986002359 cites W2015096497 @default.
• W2986002359 cites W2018754160 @default.
• W2986002359 cites W2019875624 @default.
• W2986002359 cites W2032100009 @default.
• W2986002359 cites W2043945205 @default.
• W2986002359 cites W2049116330 @default.
• W2986002359 cites W2056631765 @default.
• W2986002359 cites W2066968134 @default.
• W2986002359 cites W2075954920 @default.
• W2986002359 cites W2082508219 @default.
• W2986002359 cites W2089609590 @default.
• W2986002359 cites W2127093828 @default.
• W2986002359 cites W2131664752 @default.
• W2986002359 cites W2272984102 @default.
• W2986002359 cites W2323020638 @default.
• W2986002359 cites W2341745217 @default.
• W2986002359 cites W2505623435 @default.
• W2986002359 cites W2699278758 @default.
• W2986002359 cites W3140025388 @default.
• W2986002359 cites W4255553794 @default.
• W2986002359 doi "https://doi.org/10.1002/cncr.32586" @default.
• W2986002359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31714592" @default.
• W2986002359 hasPublicationYear "2019" @default.
• W2986002359 type Work @default.
• W2986002359 sameAs 2986002359 @default.
• W2986002359 citedByCount "22" @default.
• W2986002359 countsByYear W29860023592020 @default.
• W2986002359 countsByYear W29860023592021 @default.
• W2986002359 countsByYear W29860023592022 @default.
• W2986002359 countsByYear W29860023592023 @default.
• W2986002359 crossrefType "journal-article" @default.
• W2986002359 hasAuthorship W2986002359A5003967203 @default.
• W2986002359 hasAuthorship W2986002359A5004226726 @default.
• W2986002359 hasAuthorship W2986002359A5004613692 @default.
• W2986002359 hasAuthorship W2986002359A5006883181 @default.
• W2986002359 hasAuthorship W2986002359A5007444000 @default.
• W2986002359 hasAuthorship W2986002359A5009520487 @default.
• W2986002359 hasAuthorship W2986002359A5011303359 @default.
• W2986002359 hasAuthorship W2986002359A5015462888 @default.
• W2986002359 hasAuthorship W2986002359A5018964484 @default.
• W2986002359 hasAuthorship W2986002359A5019256105 @default.
• W2986002359 hasAuthorship W2986002359A5028187841 @default.
• W2986002359 hasAuthorship W2986002359A5028727210 @default.
• W2986002359 hasAuthorship W2986002359A5034807554 @default.
• W2986002359 hasAuthorship W2986002359A5041181413 @default.
• W2986002359 hasAuthorship W2986002359A5047460475 @default.
• W2986002359 hasAuthorship W2986002359A5048290265 @default.
• W2986002359 hasAuthorship W2986002359A5050593912 @default.
• W2986002359 hasAuthorship W2986002359A5052805520 @default.
• W2986002359 hasAuthorship W2986002359A5056742440 @default.
• W2986002359 hasAuthorship W2986002359A5060480519 @default.
• W2986002359 hasAuthorship W2986002359A5064792356 @default.
• W2986002359 hasAuthorship W2986002359A5066716873 @default.
• W2986002359 hasAuthorship W2986002359A5069216833 @default.
• W2986002359 hasAuthorship W2986002359A5069273530 @default.
• W2986002359 hasAuthorship W2986002359A5070184832 @default.

• next